カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のインフルエンザ予防接種市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Flu Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19326）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19326
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：104
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のインフルエンザ予防接種市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

インフルエンザ予防接種市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のインフルエンザ予防接種の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

インフルエンザ予防接種市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・三価インフルエンザワクチン、四価インフルエンザワクチン

用途別セグメントは次のように区分されます。
・6ヶ月～3年、3年以上

世界のインフルエンザ予防接種市場の主要な市場プレーヤーは以下のとおりです。
・Sanofi、CSL、GSK、Viatris、AstraZeneca、Hualan Bio、Changchun Institute of Biological、Sinovac、BCHT、Jiangsu GDK、KM Biologics

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、インフルエンザ予防接種製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なインフルエンザ予防接種メーカーの企業概要、2019年～2022年までのインフルエンザ予防接種の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なインフルエンザ予防接種メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別インフルエンザ予防接種の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのインフルエンザ予防接種の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのインフルエンザ予防接種市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびインフルエンザ予防接種の産業チェーンを掲載しています。
・第13、14、15章では、インフルエンザ予防接種の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- インフルエンザ予防接種の概要
- 種類別分析（2017年vs2021年vs2028年）：三価インフルエンザワクチン、四価インフルエンザワクチン
- 用途別分析（2017年vs2021年vs2028年）：6ヶ月～3年、3年以上
- 世界のインフルエンザ予防接種市場規模・予測
- 世界のインフルエンザ予防接種生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Sanofi、CSL、GSK、Viatris、AstraZeneca、Hualan Bio、Changchun Institute of Biological、Sinovac、BCHT、Jiangsu GDK、KM Biologics
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：三価インフルエンザワクチン、四価インフルエンザワクチン
・用途別分析2017年-2028年：6ヶ月～3年、3年以上
・インフルエンザ予防接種の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・インフルエンザ予防接種のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・インフルエンザ予防接種のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・インフルエンザ予防接種の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・インフルエンザ予防接種の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Flu Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Flu Vaccination market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. 6 Months to 3 Years accounting for % of the Flu Vaccination global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Trivalent Influenza Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Flu Vaccination include Sanofi, CSL, GSK, Viatris, and AstraZeneca, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Flu Vaccination market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market segment by Application can be divided into
6 Months to 3 Years
Above 3 Years
The key market players for global Flu Vaccination market are listed below:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flu Vaccination product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Flu Vaccination, with price, sales, revenue and global market share of Flu Vaccination from 2019 to 2022.
Chapter 3, the Flu Vaccination competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu Vaccination breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Flu Vaccination market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Flu Vaccination.
Chapter 13, 14, and 15, to describe Flu Vaccination sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Flu Vaccination Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Flu Vaccination Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Flu Vaccination Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 6 Months to 3 Years
1.3.3 Above 3 Years
1.4 Global Flu Vaccination Market Size & Forecast
1.4.1 Global Flu Vaccination Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Flu Vaccination Sales in Volume (2017-2028)
1.4.3 Global Flu Vaccination Price (2017-2028)
1.5 Global Flu Vaccination Production Capacity Analysis
1.5.1 Global Flu Vaccination Total Production Capacity (2017-2028)
1.5.2 Global Flu Vaccination Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Flu Vaccination Market Drivers
1.6.2 Flu Vaccination Market Restraints
1.6.3 Flu Vaccination Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Flu Vaccination Product and Services
2.1.4 Sanofi Flu Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Flu Vaccination Product and Services
2.2.4 CSL Flu Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Flu Vaccination Product and Services
2.3.4 GSK Flu Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Viatris
2.4.1 Viatris Details
2.4.2 Viatris Major Business
2.4.3 Viatris Flu Vaccination Product and Services
2.4.4 Viatris Flu Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Flu Vaccination Product and Services
2.5.4 AstraZeneca Flu Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Hualan Bio
2.6.1 Hualan Bio Details
2.6.2 Hualan Bio Major Business
2.6.3 Hualan Bio Flu Vaccination Product and Services
2.6.4 Hualan Bio Flu Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Changchun Institute of Biological
2.7.1 Changchun Institute of Biological Details
2.7.2 Changchun Institute of Biological Major Business
2.7.3 Changchun Institute of Biological Flu Vaccination Product and Services
2.7.4 Changchun Institute of Biological Flu Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sinovac
2.8.1 Sinovac Details
2.8.2 Sinovac Major Business
2.8.3 Sinovac Flu Vaccination Product and Services
2.8.4 Sinovac Flu Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 BCHT
2.9.1 BCHT Details
2.9.2 BCHT Major Business
2.9.3 BCHT Flu Vaccination Product and Services
2.9.4 BCHT Flu Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Jiangsu GDK
2.10.1 Jiangsu GDK Details
2.10.2 Jiangsu GDK Major Business
2.10.3 Jiangsu GDK Flu Vaccination Product and Services
2.10.4 Jiangsu GDK Flu Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 KM Biologics
2.11.1 KM Biologics Details
2.11.2 KM Biologics Major Business
2.11.3 KM Biologics Flu Vaccination Product and Services
2.11.4 KM Biologics Flu Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Flu Vaccination Breakdown Data by Manufacturer
3.1 Global Flu Vaccination Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Flu Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Flu Vaccination
3.4 Market Concentration Rate
3.4.1 Top 3 Flu Vaccination Manufacturer Market Share in 2021
3.4.2 Top 6 Flu Vaccination Manufacturer Market Share in 2021
3.5 Global Flu Vaccination Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Flu Vaccination Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Flu Vaccination Market Size by Region
4.1.1 Global Flu Vaccination Sales in Volume by Region (2017-2028)
4.1.2 Global Flu Vaccination Revenue by Region (2017-2028)
4.2 North America Flu Vaccination Revenue (2017-2028)
4.3 Europe Flu Vaccination Revenue (2017-2028)
4.4 Asia-Pacific Flu Vaccination Revenue (2017-2028)
4.5 South America Flu Vaccination Revenue (2017-2028)
4.6 Middle East and Africa Flu Vaccination Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Flu Vaccination Sales in Volume by Type (2017-2028)
5.2 Global Flu Vaccination Revenue by Type (2017-2028)
5.3 Global Flu Vaccination Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Flu Vaccination Sales in Volume by Application (2017-2028)
6.2 Global Flu Vaccination Revenue by Application (2017-2028)
6.3 Global Flu Vaccination Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Flu Vaccination Sales by Type (2017-2028)
7.2 North America Flu Vaccination Sales by Application (2017-2028)
7.3 North America Flu Vaccination Market Size by Country
7.3.1 North America Flu Vaccination Sales in Volume by Country (2017-2028)
7.3.2 North America Flu Vaccination Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Flu Vaccination Sales by Type (2017-2028)
8.2 Europe Flu Vaccination Sales by Application (2017-2028)
8.3 Europe Flu Vaccination Market Size by Country
8.3.1 Europe Flu Vaccination Sales in Volume by Country (2017-2028)
8.3.2 Europe Flu Vaccination Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Flu Vaccination Sales by Type (2017-2028)
9.2 Asia-Pacific Flu Vaccination Sales by Application (2017-2028)
9.3 Asia-Pacific Flu Vaccination Market Size by Region
9.3.1 Asia-Pacific Flu Vaccination Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Flu Vaccination Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Flu Vaccination Sales by Type (2017-2028)
10.2 South America Flu Vaccination Sales by Application (2017-2028)
10.3 South America Flu Vaccination Market Size by Country
10.3.1 South America Flu Vaccination Sales in Volume by Country (2017-2028)
10.3.2 South America Flu Vaccination Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Flu Vaccination Sales by Type (2017-2028)
11.2 Middle East & Africa Flu Vaccination Sales by Application (2017-2028)
11.3 Middle East & Africa Flu Vaccination Market Size by Country
11.3.1 Middle East & Africa Flu Vaccination Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Flu Vaccination Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Flu Vaccination and Key Manufacturers
12.2 Manufacturing Costs Percentage of Flu Vaccination
12.3 Flu Vaccination Production Process
12.4 Flu Vaccination Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Flu Vaccination Typical Distributors
13.3 Flu Vaccination Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Flu Vaccination Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Flu Vaccination Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Flu Vaccination Product and Services
Table 6. Sanofi Flu Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CSL Basic Information, Manufacturing Base and Competitors
Table 8. CSL Major Business
Table 9. CSL Flu Vaccination Product and Services
Table 10. CSL Flu Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Flu Vaccination Product and Services
Table 14. GSK Flu Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Viatris Basic Information, Manufacturing Base and Competitors
Table 16. Viatris Major Business
Table 17. Viatris Flu Vaccination Product and Services
Table 18. Viatris Flu Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Major Business
Table 21. AstraZeneca Flu Vaccination Product and Services
Table 22. AstraZeneca Flu Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 24. Hualan Bio Major Business
Table 25. Hualan Bio Flu Vaccination Product and Services
Table 26. Hualan Bio Flu Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 28. Changchun Institute of Biological Major Business
Table 29. Changchun Institute of Biological Flu Vaccination Product and Services
Table 30. Changchun Institute of Biological Flu Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sinovac Basic Information, Manufacturing Base and Competitors
Table 32. Sinovac Major Business
Table 33. Sinovac Flu Vaccination Product and Services
Table 34. Sinovac Flu Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. BCHT Basic Information, Manufacturing Base and Competitors
Table 36. BCHT Major Business
Table 37. BCHT Flu Vaccination Product and Services
Table 38. BCHT Flu Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 40. Jiangsu GDK Major Business
Table 41. Jiangsu GDK Flu Vaccination Product and Services
Table 42. Jiangsu GDK Flu Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 44. KM Biologics Major Business
Table 45. KM Biologics Flu Vaccination Product and Services
Table 46. KM Biologics Flu Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Flu Vaccination Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Units)
Table 48. Global Flu Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Flu Vaccination, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Flu Vaccination Production Capacity by Company, (Units): 2020 VS 2021
Table 51. Head Office and Flu Vaccination Production Site of Key Manufacturer
Table 52. Flu Vaccination New Entrant and Capacity Expansion Plans
Table 53. Flu Vaccination Mergers & Acquisitions in the Past Five Years
Table 54. Global Flu Vaccination Sales by Region (2017-2022) & (Units)
Table 55. Global Flu Vaccination Sales by Region (2023-2028) & (Units)
Table 56. Global Flu Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Flu Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Flu Vaccination Sales by Type (2017-2022) & (Units)
Table 59. Global Flu Vaccination Sales by Type (2023-2028) & (Units)
Table 60. Global Flu Vaccination Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Flu Vaccination Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Flu Vaccination Price by Type (2017-2022) & (US$/Unit)
Table 63. Global Flu Vaccination Price by Type (2023-2028) & (US$/Unit)
Table 64. Global Flu Vaccination Sales by Application (2017-2022) & (Units)
Table 65. Global Flu Vaccination Sales by Application (2023-2028) & (Units)
Table 66. Global Flu Vaccination Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Flu Vaccination Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Flu Vaccination Price by Application (2017-2022) & (US$/Unit)
Table 69. Global Flu Vaccination Price by Application (2023-2028) & (US$/Unit)
Table 70. North America Flu Vaccination Sales by Country (2017-2022) & (Units)
Table 71. North America Flu Vaccination Sales by Country (2023-2028) & (Units)
Table 72. North America Flu Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Flu Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Flu Vaccination Sales by Type (2017-2022) & (Units)
Table 75. North America Flu Vaccination Sales by Type (2023-2028) & (Units)
Table 76. North America Flu Vaccination Sales by Application (2017-2022) & (Units)
Table 77. North America Flu Vaccination Sales by Application (2023-2028) & (Units)
Table 78. Europe Flu Vaccination Sales by Country (2017-2022) & (Units)
Table 79. Europe Flu Vaccination Sales by Country (2023-2028) & (Units)
Table 80. Europe Flu Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Flu Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Flu Vaccination Sales by Type (2017-2022) & (Units)
Table 83. Europe Flu Vaccination Sales by Type (2023-2028) & (Units)
Table 84. Europe Flu Vaccination Sales by Application (2017-2022) & (Units)
Table 85. Europe Flu Vaccination Sales by Application (2023-2028) & (Units)
Table 86. Asia-Pacific Flu Vaccination Sales by Region (2017-2022) & (Units)
Table 87. Asia-Pacific Flu Vaccination Sales by Region (2023-2028) & (Units)
Table 88. Asia-Pacific Flu Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Flu Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Flu Vaccination Sales by Type (2017-2022) & (Units)
Table 91. Asia-Pacific Flu Vaccination Sales by Type (2023-2028) & (Units)
Table 92. Asia-Pacific Flu Vaccination Sales by Application (2017-2022) & (Units)
Table 93. Asia-Pacific Flu Vaccination Sales by Application (2023-2028) & (Units)
Table 94. South America Flu Vaccination Sales by Country (2017-2022) & (Units)
Table 95. South America Flu Vaccination Sales by Country (2023-2028) & (Units)
Table 96. South America Flu Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Flu Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Flu Vaccination Sales by Type (2017-2022) & (Units)
Table 99. South America Flu Vaccination Sales by Type (2023-2028) & (Units)
Table 100. South America Flu Vaccination Sales by Application (2017-2022) & (Units)
Table 101. South America Flu Vaccination Sales by Application (2023-2028) & (Units)
Table 102. Middle East & Africa Flu Vaccination Sales by Region (2017-2022) & (Units)
Table 103. Middle East & Africa Flu Vaccination Sales by Region (2023-2028) & (Units)
Table 104. Middle East & Africa Flu Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Flu Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Flu Vaccination Sales by Type (2017-2022) & (Units)
Table 107. Middle East & Africa Flu Vaccination Sales by Type (2023-2028) & (Units)
Table 108. Middle East & Africa Flu Vaccination Sales by Application (2017-2022) & (Units)
Table 109. Middle East & Africa Flu Vaccination Sales by Application (2023-2028) & (Units)
Table 110. Flu Vaccination Raw Material
Table 111. Key Manufacturers of Flu Vaccination Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Flu Vaccination Typical Distributors
Table 115. Flu Vaccination Typical Customers
List of Figures
Figure 1. Flu Vaccination Picture
Figure 2. Global Flu Vaccination Revenue Market Share by Type in 2021
Figure 3. Trivalent Influenza Vaccine
Figure 4. Quadrivalent Influenza Vaccine
Figure 5. Global Flu Vaccination Revenue Market Share by Application in 2021
Figure 6. 6 Months to 3 Years
Figure 7. Above 3 Years
Figure 8. Global Flu Vaccination Revenue, (USD Million) & (Units): 2017 & 2021 & 2028
Figure 9. Global Flu Vaccination Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Flu Vaccination Sales (2017-2028) & (Units)
Figure 11. Global Flu Vaccination Price (2017-2028) & (US$/Unit)
Figure 12. Global Flu Vaccination Production Capacity (2017-2028) & (Units)
Figure 13. Global Flu Vaccination Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Flu Vaccination Market Drivers
Figure 15. Flu Vaccination Market Restraints
Figure 16. Flu Vaccination Market Trends
Figure 17. Global Flu Vaccination Sales Market Share by Manufacturer in 2021
Figure 18. Global Flu Vaccination Revenue Market Share by Manufacturer in 2021
Figure 19. Flu Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Flu Vaccination Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Flu Vaccination Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Flu Vaccination Sales Market Share by Region (2017-2028)
Figure 23. Global Flu Vaccination Revenue Market Share by Region (2017-2028)
Figure 24. North America Flu Vaccination Revenue (2017-2028) & (USD Million)
Figure 25. Europe Flu Vaccination Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Flu Vaccination Revenue (2017-2028) & (USD Million)
Figure 27. South America Flu Vaccination Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Flu Vaccination Revenue (2017-2028) & (USD Million)
Figure 29. Global Flu Vaccination Sales Market Share by Type (2017-2028)
Figure 30. Global Flu Vaccination Revenue Market Share by Type (2017-2028)
Figure 31. Global Flu Vaccination Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Flu Vaccination Sales Market Share by Application (2017-2028)
Figure 33. Global Flu Vaccination Revenue Market Share by Application (2017-2028)
Figure 34. Global Flu Vaccination Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Flu Vaccination Sales Market Share by Type (2017-2028)
Figure 36. North America Flu Vaccination Sales Market Share by Application (2017-2028)
Figure 37. North America Flu Vaccination Sales Market Share by Country (2017-2028)
Figure 38. North America Flu Vaccination Revenue Market Share by Country (2017-2028)
Figure 39. United States Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Flu Vaccination Sales Market Share by Type (2017-2028)
Figure 43. Europe Flu Vaccination Sales Market Share by Application (2017-2028)
Figure 44. Europe Flu Vaccination Sales Market Share by Country (2017-2028)
Figure 45. Europe Flu Vaccination Revenue Market Share by Country (2017-2028)
Figure 46. Germany Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Flu Vaccination Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Flu Vaccination Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Flu Vaccination Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Flu Vaccination Revenue Market Share by Region (2017-2028)
Figure 55. China Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Flu Vaccination Sales Market Share by Type (2017-2028)
Figure 62. South America Flu Vaccination Sales Market Share by Application (2017-2028)
Figure 63. South America Flu Vaccination Sales Market Share by Country (2017-2028)
Figure 64. South America Flu Vaccination Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Flu Vaccination Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Flu Vaccination Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Flu Vaccination Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Flu Vaccination Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Flu Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Flu Vaccination in 2021
Figure 76. Manufacturing Process Analysis of Flu Vaccination
Figure 77. Flu Vaccination Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の肺炎球菌ワクチン接種市場2022年：市場規模予測（～2028年）
  • 世界の黄熱病用予防接種市場2022年：市場規模予測（～2028年）
  • 世界の旅行者用予防接種市場2022年：市場規模予測（～2028年）
  • 世界のA型肝炎ワクチン接種市場2022年：市場規模予測（～2028年）
  • 世界の水痘ワクチン接種市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19326 )"世界のインフルエンザ予防接種市場2022年：市場規模予測（～2028年）" (英文：Global Flu Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。